Skip to main content
. 2011 Oct 5;16(12):1684–1697. doi: 10.1634/theoncologist.2011-0113

Table 4.

Comparisons of ECOG-2100, AVADO, and RIBBOn-1 trials: Efficacy results

graphic file with name onc01211-0921-t04.jpg

Abbreviations: A, anthracycline; AVADO, Avastin and Docetaxel; Bev, bevacizumab; CAP, capecitabine; Doc, docetaxel; ECOG, Eastern Cooperative Oncology Group; NR, no results; Pac, paclitaxel; Pla, placebo; RIBBOn, Regimens in Bevacizumab for Breast Oncology; R1-Cap, RIBBOn-1/capecitabine; R1-T/Anth, RIBBOn-1/taxane and anthracycline; T, Taxanes.